Cargando…
Levosimendan. A promising future drug for refractory cardiac failure in children?
Intravenous positive inotropic agents play an important role in treating acute decompensation of patients with heart failure due to left ventricular systolic dysfunction. Levosimendan is a new positive inotropic agent having ATP-dependent potassium-channel opening, and calcium-sensitizing effects, w...
Autores principales: | Kushwah, Supriya, Kumar, Ashutosh, Sahana, K.S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4824328/ https://www.ncbi.nlm.nih.gov/pubmed/27056655 http://dx.doi.org/10.1016/j.ihj.2015.09.013 |
Ejemplares similares
-
Levosimendan in trauma patients with acute cardiac failure
por: Afonin, AN, et al.
Publicado: (2011) -
Levosimendan Plus Dobutamine in Acute Decompensated Heart Failure Refractory to Dobutamine
por: Juguet, William, et al.
Publicado: (2020) -
Levosimendan/norepinephrine: Lack of drug effect: case report
Publicado: (2020) -
Preoperative optimization with levosimendan in heart failure patient undergoing thoracic surgery
por: Nespoli, Moana Rossella, et al.
Publicado: (2016) -
Levosimendan Improves Clinical Outcomes of Refractory Heart Failure in Elderly Chinese Patients
por: Zhang, Dengqing, et al.
Publicado: (2015)